Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Formation of Muscle Fibers from Myoblasts01:13

Formation of Muscle Fibers from Myoblasts

5.7K
De novo myogenesis, or the formation of muscle fibers, begins during the early embryonic stages. The skeletal muscle is formed from somites– blocks of embryonic cell layers. The somites are further divided into dermatomes, myotomes, sclerotomes, and syndetomes. Among these, the myotomes give rise to muscle fibers.
Muscle progenitor cells (MPCs) are formed from the myotomes. MPCs express genes that encode the transcription factors Pax3 and Pax7. Along with Pax 3/7, other transcription...
5.7K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

4.5K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.5K
Protein Translocation Machinery on the ER Membrane01:28

Protein Translocation Machinery on the ER Membrane

6.4K
The translocon complex situated on the ER membrane is the main gateway for the protein secretory pathway. It facilitates the transport of nascent peptides into the ER lumen and their insertion into the ER membrane.
Sec61 protein conducting channel
In eukaryotes, the translocon complex comprises a core heterotrimeric translocator channel called the Sec61 complex. This channel includes three transmembrane proteins, Sec61α, Sec61β, and Sec61γ, and is the largest subunit of the...
6.4K
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

7.6K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
7.6K
Role of Myosin in Cell Migration01:18

Role of Myosin in Cell Migration

3.1K
Myosins are multimeric motor proteins involved in various cellular processes such as migration, adhesion, and proliferation. Myosin II is the most common type in animal cells, which binds and cross-links actin filaments.
Myosin II  is a hexamer comprising two heavy chains with globular heads and coiled-coil tails, two regulatory light chains, and two essential light chains. The ATPase sites on the myosin heads hydrolyze ATP, and the released phosphate generates the force for contraction....
3.1K
Abnormal Proliferation02:23

Abnormal Proliferation

5.0K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.0K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Causal Effect of Type 1 Diabetes on Juvenile Idiopathic Arthritis and the Mediating Role of CD8+ Natural Killer T Cells.

The Journal of clinical endocrinology and metabolism·2025
Same author

IL-17 promotes osteoclast-induced bone loss by regulating glutamine-dependent energy metabolism.

Cell death & disease·2024
Same author

Higher risk of osteoporosis in adult-onset asthma than childhood-onset asthma: from genetic and prospective evidence.

Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·2023
Same author

Incidence, prevalence and disability of spinal cord injury in China from 1990 to 2019: a systematic analysis of the Global Burden of Disease Study 2019.

European spine journal : official publication of the European Spine Society, the European Spinal Deformity Society, and the European Section of the Cervical Spine Research Society·2022
Same author

Gene-Environment Interaction on Type 2 Diabetes Risk among Chinese Adults Born in Early 1960s.

Genes·2022
Same author

An External Patient Healthcare Index (EPHI) for Simulating Spatial Tendencies in Healthcare Seeking Behavior.

Frontiers in public health·2022

Related Experiment Video

Updated: Jan 2, 2026

DNA Electroporation, Isolation and Imaging of Myofibers
07:52

DNA Electroporation, Isolation and Imaging of Myofibers

Published on: December 23, 2015

12.8K

Myoferlin, a Membrane Protein with Emerging Oncogenic Roles.

Yimin Dong1, Honglei Kang1, Huiyong Liu1

  • 1Department of Orthopedic Surgery, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.

Biomed Research International
|December 13, 2019
PubMed
Summary

Myoferlin (MYOF) is a muscle protein now recognized as an oncogene. Overexpression of MYOF in cancers drives tumor progression and metastasis, suggesting it as a potential therapeutic target.

More Related Videos

Author Spotlight: Tracing the Ferroptotic Signatures and Cell Death Dynamics in Medulloblastoma for Advanced Therapeutics
04:01

Author Spotlight: Tracing the Ferroptotic Signatures and Cell Death Dynamics in Medulloblastoma for Advanced Therapeutics

Published on: March 15, 2024

1.8K
Characterization of Cell Membrane Extensions and Studying Their Roles in Cancer Cell Adhesion Dynamics
08:11

Characterization of Cell Membrane Extensions and Studying Their Roles in Cancer Cell Adhesion Dynamics

Published on: March 26, 2018

8.7K

Related Experiment Videos

Last Updated: Jan 2, 2026

DNA Electroporation, Isolation and Imaging of Myofibers
07:52

DNA Electroporation, Isolation and Imaging of Myofibers

Published on: December 23, 2015

12.8K
Author Spotlight: Tracing the Ferroptotic Signatures and Cell Death Dynamics in Medulloblastoma for Advanced Therapeutics
04:01

Author Spotlight: Tracing the Ferroptotic Signatures and Cell Death Dynamics in Medulloblastoma for Advanced Therapeutics

Published on: March 15, 2024

1.8K
Characterization of Cell Membrane Extensions and Studying Their Roles in Cancer Cell Adhesion Dynamics
08:11

Characterization of Cell Membrane Extensions and Studying Their Roles in Cancer Cell Adhesion Dynamics

Published on: March 26, 2018

8.7K

Area of Science:

  • Molecular Biology
  • Oncology
  • Cell Biology

Background:

  • Myoferlin (MYOF) is a Ferlin family protein crucial for membrane dynamics in muscle cells.
  • MYOF dysfunction is linked to muscular disorders.
  • Emerging evidence implicates MYOF in cancer development and progression.

Purpose of the Study:

  • To review the physiological roles of Myoferlin (MYOF).
  • To elucidate the oncogenic functions of MYOF in various human cancers.
  • To provide a comprehensive understanding of MYOF for future research and therapeutic strategies.

Main Methods:

  • Literature review of studies on Myoferlin (MYOF) function and cancer association.
  • Analysis of MYOF's role in tumorigenesis, metastasis, and cellular processes.
  • Evaluation of MYOF as a prognostic marker and therapeutic target.

Main Results:

  • MYOF is overexpressed in multiple human cancers, correlating with poor patient outcomes.
  • MYOF promotes key oncogenic processes: tumorigenesis, motility, proliferation, angiogenesis, and metastasis.
  • MYOF influences crucial cellular functions including receptor trafficking, metabolism, and mitochondrial maintenance.

Conclusions:

  • Myoferlin (MYOF) acts as an oncogenic protein driving cancer progression.
  • MYOF overexpression serves as a prognostic indicator in various malignancies.
  • Targeting MYOF presents a promising therapeutic strategy for cancer treatment.